Safety and Efficacy of Vibro-tactile Feedback for Patients Who Underwent Lower Limb Amputation

NCT ID: NCT05895253

Last Updated: 2023-06-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-25

Study Completion Date

2022-05-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prosthetics research has grown recently, focusing on bionic approaches that restore bodily functions with technical aids. One method involves using prostheses with feedback systems, which measure physical parameters and provide additional information to the user. Saphenus has developed a feedback system called Suralis© that transfers pressure signals from the prosthetic sole to another body region. This clinical investigation aimed to determine if this system improves gait stability and walking. The study analyzed changes in gait and functional balance and gathered patient-reported measures to evaluate the quality of life.

This research was open to individuals who have undergone below-knee amputation but no targeted re-innervation surgery and use prosthetics. Participants received the Suralis© feedback system, and the investigators assessed their walking activities. The system measures prosthetic foot sole pressure and converts it into digital signals, triggering vibration stimuli during the stance phase of walking. The investigators collected gait analyses and patient feedback to assess the impact of the feedback system on prosthetic management. The results will help us understand the benefits and effectiveness of this technology for people with amputation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators conducted a prospective, unblinded crossover trial to compare the effectiveness of a vibration intervention with no intervention. Participants were randomly assigned to one of two sequences: vibration intervention followed by no intervention or vice versa. The intervention involved using the Suralis© vibrotactile ground-contact feedback system for 60 days. The system transmitted ground contact information to the residual lateral thigh, providing sensory feedback. During the control phase, participants received no additional intervention. The washout period lasted seven days. The study collected data during four visits, assessing gait and patient-reported measures. Bayesian generalized linear mixed models were used for data analysis, considering fixed effects (intervention, sequence, and period) and random effects (individuality).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amputation of Lower Limb Below Knee Unilateral

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control-Vibration

Participants were assessed before and after 60 days of no additional intervention to any ongoing treatment, after seven days of washout, and after receiving 60 days of vibrotactile ground-contact feedback.

Group Type ACTIVE_COMPARATOR

vibrotactile ground-contact feedback

Intervention Type DEVICE

Suralis®, Saphenus Medical Technology (Baden, Lower Austria, Austria)

Vibration-Control

Participants were assessed before and after receiving 60 days of vibrotactile ground-contact feedback, after seven days of washout, and after 60 days of no additional intervention to any ongoing treatment.

Group Type ACTIVE_COMPARATOR

vibrotactile ground-contact feedback

Intervention Type DEVICE

Suralis®, Saphenus Medical Technology (Baden, Lower Austria, Austria)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

vibrotactile ground-contact feedback

Suralis®, Saphenus Medical Technology (Baden, Lower Austria, Austria)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* male, female, and diverse individuals
* unilateral transtibial amputation
* at least 18 months post surgery
* walking without aids possible
* signed informed consent form

Exclusion Criteria

* insufficient thigh sensation to distinguish between the two closest vibrotactile actuators
* an acute event that restricts the walking ability
* interfering lesions or painful conditions
* undergone targeted re-innervation surgery
* poor stump condition
* used a non-modular prosthesis
* used a prosthesis in poor condition
* conditions preventing safe participation or interfering with study objectives
* not able to not comply with the protocol
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Saphenus Medical Technology GmbH

INDUSTRY

Sponsor Role collaborator

Ludwig Boltzmann Institute for Traumatology - The research center in cooperation with AUVA

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gerfried Peternell, MD

Role: PRINCIPAL_INVESTIGATOR

Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with the AUVA

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ordination Dr. Wolfgang Schaden

Vienna, , Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

References

Explore related publications, articles, or registry entries linked to this study.

Penasso H, Peternell G, Schultheis R, Pitschl A, Leskovar R, Gardetto A, Ernst J, Schmid-Zalaudek K, Schaden W. Safety and efficacy of vibrotactile feedback for adults with transtibial amputation: A randomized controlled cross-over trial. Clin Biomech (Bristol). 2025 Apr;124:106443. doi: 10.1016/j.clinbiomech.2025.106443. Epub 2025 Feb 10.

Reference Type DERIVED
PMID: 40054381 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IPS002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.